#1 |
migraine[Text Word] |
#11 |
preventive therapy[Text Word] |
#40 |
beta-blocker[Text Word] |
#85 |
randomized controlled trial[Text Word] |
#2 |
episodic migraine[Text Word] |
#12 |
prophylaxis[Text Word] |
#41 |
topiramate[Text Word] |
#86 |
controlled clinical trial[Text Word] |
#3 |
chronic migraine[Text Word] |
#13 |
treatment[Text Word] |
#42 |
anticonvu*[Text Word] |
#87 |
randomized controlled*[Text Word] |
#4 |
migraine with aura[Text Word] |
#14 |
therapies[Title/Abstract] |
#43 |
antiepilep*[Text Word] |
#88 |
random allocation[Title/Abstract] |
#5 |
migraine without aura[Text Word] |
#15 |
prevention[Text Word] |
#44 |
topira*[Text Word] |
#89 |
Double-Blind Method[MeSH Terms] |
#6 |
migrain*[Text Word] |
#16 |
prophylactic[Text Word] |
#45 |
valproate[Text Word] |
#90 |
Single-Blind Method[MeSH Terms] |
#7 |
cephalgi*[Text Word] |
#17 |
preventive treatment[Text Word] |
#46 |
valpro*[Text Word] |
#91 |
clinical trial[Text Word] |
#8 |
migraine*[Text Word] |
#18 |
pharmacologic[Title/Abstract] |
#47 |
candesartan[Text Word] |
#92 |
clinical trials[Text Word] |
#9 |
cephalalgi*[Text Word] |
#19 |
prevent*[Text Word] |
#48 |
candesart*[Text Word] |
#93 |
Prospective Studies[MeSH Terms] |
#10 |
Migraine Disorders [Mesh Terms] |
#20 |
drug*[Text Word] |
#49 |
onabotulinum[Text Word] |
#94 |
control*[Text Word] |
|
|
#21 |
preventative*[Title/Abstract] |
#50 |
botox[Text Word] |
#95 |
prospectiv*[Text Word] |
|
|
#22 |
therapy[Title/Abstract] |
#51 |
onabotulinum*[Text Word] |
#96 |
Placebos[MeSH Terms] |
|
|
#23 |
effective[Title/Abstract] |
#52 |
erenumab[Text Word] |
#97 |
placebo*[Text Word] |
|
|
#24 |
frequency*[Title/Abstract] |
#53 |
CGRP[Text Word] |
#98 |
random*[Text Word] |
|
|
#25 |
reduction[Title/Abstract] |
#54 |
anti-CGRP[Text Word] |
#99 |
blind*[Text Word] |
|
|
#26 |
reduces[Title/Abstract] |
#55 |
Calcitonin Gene-Related*[Text Word] |
#100 |
Evaluation Studies as Topic[MeSH Terms] |
|
|
#27 |
reduced[Title/Abstract] |
#56 |
gepants[Text Word] |
#101 |
Comparative Study[Publication Type] |
|
|
#28 |
attack*[Title/Abstract] |
#57 |
*gepant[Text Word] |
#102 |
trial*[Text Word] |
|
|
#29 |
month*[Text Word] |
#58 |
Valproic Acid[MeSH Terms] |
#103 |
controll*[Text Word] |
|
|
#30 |
therapeutic[Title/Abstract] |
#59 |
Botulinum Toxins, Type A[MeSH Terms] |
#104 |
efficacy*[Text Word] |
|
|
#31 |
effectively[Title/Abstract] |
#60 |
Amitriptyline[MeSH Terms] |
#105 |
compare*[Text Word] |
|
|
#32 |
effect[Title/Abstract] |
#61 |
fremanezumab[Supplementary Concept] |
#106 |
Clinical Trials as Topic[MeSH Terms] |
|
|
#33 |
Prevention and Control[MeSH Terms] |
#62 |
TEV-48125[Text Word] |
#107 |
*blind*[Text Word] |
|
|
#34 |
Drug Therapy[MeSH Terms] |
#63 |
galcanezumab[Supplementary Concept] |
#108 |
Multicenter Study[Publication Type] |
|
|
#35 |
Treatment Outcome [MeSH Terms] |
#64 |
eptinezumab[Supplementary Concept] |
#109 |
Clinical Studies as Topic[MeSH Terms] |
|
|
#36 |
Therapeutic Use [MeSH Subheading] |
#65 |
telcagepant[Supplementary Concept] |
#110 |
Cross-Over Studies[MeSH Terms] |
|
|
#37 |
monthly[Text Word] |
#66 |
Propranolol[MeSH Terms] |
#111 |
Clinical Trial[Publication Type] |
|
|
#38 |
outcome*[Text Word] |
#67 |
Metoprolol[MeSH Terms] |
#112 |
Drug Evaluation[MeSH Terms] |
|
|
#39 |
preventative treatment[Text Word] |
#68 |
Nebivolol[MeSH Terms] |
#113 |
Preliminary Data[MeSH Terms] |
|
|
|
|
#69 |
Adrenergic Beta-Antagonists[MeSH Terms] |
#114 |
pivot*[Text Word] |
|
|
|
|
#70 |
Bisoprolol[MeSH Terms] |
#115 |
Review Literature as Topic[MeSH Terms] |
|
|
|
|
#71 |
Flunarizine[MeSH Terms] |
#116 |
Systematic Review[Publication Type] |
|
|
|
|
#72 |
Verapamil[MeSH Terms] |
#117 |
Review[Publication Type] |
|
|
|
|
#73 |
Anticonvulsants[MeSH Terms] |
|
|
|
|
|
|
#74 |
Calcitonin Gene-Related Peptide[MeSH Terms] |
|
|
|
|
|
|
#75 |
Receptors, Calcitonin Gene-Related Peptide[MeSH Terms] |
|
|
|
|
|
|
#76 |
atogepant[Text Word] |
|
|
|
|
|
|
#77 |
rimegepant[Text Word] |
|
|
|
|
|
|
#78 |
Pituitary Adenylate Cyclase-Activating Polypeptide[MeSH Terms] |
|
|
|
|
|
|
#79 |
PACAP*[Text Word] |
|
|
|
|
|
|
#80 |
AMG334[Text Word] |
|
|
|
|
|
|
#81 |
PAC1[Text Word] |
|
|
|
|
|
|
#82 |
filorexant[Text Word] |
|
|
|
|
|
|
#83 |
orexin[Text Word] |
|
|
|
|
|
|
#84 |
LBR-101[Text Word] |
|
|